[PDF] Top 20 A coisa julgada no âmbito das ações de investigação de paternidade

... the patients, who didn’t achieve MMR at 12 or 18, IM dose escalation and switching to second-line TKIs were observed only in 64 ...the patients were diagnosed with CML before 2013, and the change in the ... See full document

... successful treatment-free remission ...this chronic therapy may impact patient’ s lives by either its associated adverse events (such as peripheral edema and muscle cramps with imatinib, pleural effusions ... See full document

... imatinib treatment for F/P fusion gene positive CEL has been ...early study included 4 cases administered imatinib for a median of ...imatinib treatment of ...imatinib treatment for a median ... See full document

... 3 study of three induction protocols and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the East- ern Cooperative Oncology ... See full document

... Our study had many limitations, lack of diagnostic tools for confirmation of the diagnosis of fungal infections like galactomannan antigen as a marker of invasive aspergillosis or B-d glucan as pan-fungal marker, ... See full document

... in chronic phase at the time of progression appeared to do better with second generation TKIs rather than allogeneic stem cell ...some patients were referred for transplantation and others ...dasatinib ... See full document

... Diagnosed Patients (ENESTnd) study compared two doses of nilotinib (400 mg twice daily and 300 mg twice daily) with imatinib 400 mg daily ...1). Patients treated with nilotinib had a significantly ... See full document

... CML patients (5 citizens and 31 noncitizen residents) consented to participate in the ...36 patients, 22 (61%) were classified as adherent (mean: 95) and 14 (39%) were classified as nonadherent (mean: ... See full document

... some patients who were apparently compliant during patient interview, had been noted in the past to be ...13 patients were also included in the non-compliant group – giving a total non- compliance rate of ... See full document

... for patients with newly diagnosed CML-CP, drug selection for initial ther- apy depends on disease risk and ...[4]. Patients who have intermediate or high Sokal risk scores stand to benefit from ... See full document

... study. Patients were treated with imatinib for a mean dura- tion of ...of patients were found to be growth hormone-deficient, with 89% having IGF-1 z-scores below the mean and 100% of patients ... See full document

... CML patients, imatinib does not appear to lead to a cure of the disease due to development of point mutations in the ATP binding region of BCR-ABL and the insensitiv- ity of quiescent leukemic stem cells to ... See full document

... high treatment-related mortality and poor outcomes, many older patients choose less aggressive therapy, often at the recommendation of their ...a study by Ferrara, et al questionnaires were ... See full document

... CML patients come to expect increasingly longer survival with TKI therapy, the importance of managing symp- tom burden related to the disease and its treatment will also ...the patients’ response to ... See full document

... for patients with no suitable donor or who are not eligible for transplantation, better understanding of the effects of DAS on the immune system may offer hopeful future ... See full document

... with treatment, medical insurance, and patient assistant program were also ...TKIs, treatment goals, attitudes, and reasons for TFR for CML patients were also ...domains. Treatment goals for ... See full document

... Acromegaly is a rare, slowly progressive disorder result- ing from excessive growth hormone (GH) production by a pituitary somatotroph tumor. GH produces direct metabolic effects and induces hepatic insulin-like growth ... See full document

... The reasons for these advancements are several, but the main driver has been the increased and improved understanding of the multiplicity of intracellular pathways that could be affected during the oncogenic process, ... See full document

... acute myeloid leukaemia [12]. A prospective observational study in University of Nigeria Teaching Hospital showed a prevalence of leukaemic ophthalmopathy of ...these patients present ... See full document

... of chronic myeloid leukemia (CML) has changed dramatically in the last ...of patients either present with primary resistance to imatinib or develop secondary resistance sooner or later during ... See full document